Elena Ridloff - 06 Aug 2026 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Reporting relationship
Director
Issuer ticker
IMUX
Reported as of
06 Aug 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Aug 2026, 19:00:13 UTC
Prior SEC filing
25 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elena Ridloff

Key filing fact

Elena Ridloff filed Form 4 for IMMUNIC, INC. (IMUX) on 10 Aug 2026.

Key facts

  • This page summarizes Elena Ridloff's Form 4 filing for IMMUNIC, INC. (IMUX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 10 Aug 2026, 19:00.

Change

  • Previous filing in this sequence was filed on 25 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001772518 Primary reporting owner

Ridloff Elena

Relationship
Director
Address
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK
Signature
/s/ Elena Ridloff
Signature date
10 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMUX transaction Derivative

Stock Option

Award

Transaction value
Shares
+50,740
Change %
Price
$0.000000*
Shares after
50,740
Date
06 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,740
Exercise price
$14.54
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest in monthly increments over a period of three years from the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .